LASER TECHNOLOGIES IN THE CORRECTION OF NONNEOPLASTIC MELANIN HYPERPIGMENTATION OF THE SKIN

Abstract

The article briefly describes the modern views on the main causes of nonneoplastic melanin hyperpigmentation of the skin and also consider various types of laser and light therapy and effective combination of some methods of treatment. Under observation were 30 patients with nonneoplastic hyperpigmentation of the skin on both sides of the face (solar lentigo, ephelides, melasma, posttraumatic hyperpigmentation), skin type I-III. Patients were treated with using a neodymium laser (1064 nm) with low fluence per half of the face and an alexandrite laser (755 nm) with low fluence to the other half of the face in the same procedure. A total of 4 procedures were performed with a weekly interval. Both variants of therapy were equally effective in the treatment of nonneoplastic melanin hyperpigmentation of the skin and showed a high safety profile.

Keywords

hyperpigmentation / melasma / lentigo / laser / alexandrite laser / neodymium laser / laser therapy

References

[1] Franck P., Henderson P.W., Rothaus K.O. Basics of lasers: history, physics, and clinical applications. Clin. Plast. Surg. 2016; 43(3): 505-13

[2] Шептий О.В., Круглова Л.С., Жукова О.В., Эктова Т.В., Ракша Д.А., Шматова А.А. Высокоэнергетическое лазерное излучение в дерматологии и косметологии. Российский журнал кожных и венерических болезней. 2012; (6): 39-43

[3] Rodriguez-Arambula A., Torres-Alvarez B., Cortes-Garcia D., Fuentes-Ahumada C., Castanedo-Cazares J.P. CD4, IL-17, and COX-2 are associated with subclinical inflammation in malar melasma. Am. J. Dermatopathol. 2015; 37(10): 761-6

[4] Потекаев Н.Н., Круглова Л.С. Гиперпигментация: причины возникновения и методы коррекции. Клиническая дерматология и венерология. 2012; 10(6): 65-70

[5] Lee A.Y. Recent progress in melasma pathogenesis. Pigment Cell Melanoma Res. 2015; 28(6): 648-60.

[6] Sirimahachaiyakul P., Sood R.F., Muffley L.A., Seaton M., Lin C.T., Qiao L. et al. Race does not predict melanocyte heterogeneous responses to dermal fibroblast-derived mediators. PLoS One. 2015; 10(9): e0139135.

[7] Круглова Л.С., Стенько А.Г., Стрелкович Т.И. Этиология, патогенез, классификация и современные возможности лечения неопухолевых гиперпигментаций кожи. Пластическая хирургия и косметология. 2014; (1): 105-10

[8] Duval С., Cohen С., Chagnoleau С., Flouret V., Bourreau E., F. Slominski. Key regulatory role of dermal fibroblasts in pigmentation as demonstrated using a reconstructed skin model: impact of photo-aging. PLoS One. 2014; 9(12): e114182.

[9] Nguyen B., Tawata S. Mimosine dipeptide enantiomsers: improved inhibitors against melanogenesis and cyclooxygenase. Molecules. 2015; 20(8): 14334-47.

[10] Марголина А.А., Петрухина А.О. Современные подходы к отбеливанию кожи. Часть 1. Меланины и кожа. Косметика и медицина. 2001; (1): 4-13.

[11] Олисова О.Ю., Андреева Е.В. Еще раз о проблеме гиперпигментации. Российский журнал кожных и венерических болезней. 2014; 2(17): 20-4.

[12] Kwon S.H., Hwang Y.J., Lee S.K., Park K.C. Heterogeneous pathology of melasma and its clinical implications. Int. J. Mol. Sci. 2016; 17(6): 824.

[13] Hirobe T., Ishikawa A. l-tyrosine induces melanocyte differentiation in novel pink-eyed dilution castaneus mouse mutant showing age-related pigmentation. J. Dermatol. Sci. 2015; 80(3): 203-11.

[14] Потекаев Н.Н., Круглова Л.С. Лазер в дерматологии и косметологии. М.; 2012.

[15] Круглова Л.С., Котенко К.В., Корчажкина Н.Б., Турбовская С.Н. Физиотерапия в дерматологии. М.; 2016.

[16] Ibrahim Z.A., Gheida S.F., El Maghraby G.M., Farag Z.E. Evaluation of the efficacy and safety of combinations of hydroquinone, glycolic acid, and hyaluronic acid in the treatment of melasma. J. Cosmet. Dermatol. 2015; 14(2): 113-23.

[17] Gilchrest B.A. A review of skin ageing and its medical therapy. Br. J. Dermatol. 1996; 135(6): 867-75.

[18] Bang S.H., Han S.J., Kim D.H. Hydrolysis of arbutin to hydroquinone by human skin bacteria and its effect on antioxidant activity. J. Cosmet. Dermatol. 2008; 7(3): 189-93.

[19] Chaudhary S., Dayal S. Efficacy of combination of glycolic acid peeling with topical regimen in treatment of melasma. J. Drugs. Dermatol. 2013; 12(10): 1149-53.

[20] Patil U.A., Dhami L.D. Overview of lasers. Indian J. Plast. Surg. 2008; 41: 101-13.

[21] Vashi N.A., Kundu R.V. Facial hyperpigmentation: causes and treatment. Br. J. Dermatol. 2013; 169(3): 41-56.

[22] Kim J.E., Chang S.E., Yeo U.C., Haw S., Kim I.H. Histopathological study of the treatment of melasma lesions using a low-fluence Q-switched 1064-nm neodymium:yttrium-aluminium-garnet laser. Clin. Exp. Dermatol. 2013; 38: 167-171.

[23] Шептий О.В., Круглова Л.С., Корчажкина Н.Б., Котенко К.В., Яменсков В.В. Механизмы действия различных лазеров и дифференцированные показания к их применению (oбзор литературы). Вестник новых медицинских технологий. 2014; (1)

[24] Augustyniak A., Erkiert-Polguj A., Rotsztejn H. Variable pulsed light treatment of melasma and post-inflammatory hyperpigmentation - a pilot study. J. Cosmet. Laser Ther. 2015; 17(1): 15-9.

[25] Park J.H., Kim J.I., Kim W.S. Treatment of persistent facial postinflammatory hyperpigmentation with novel pulse-in-pulse Mode Intense pulsed light. Dermatol. Surg. 2016; 42(2): 218-24.

RIGHTS & PERMISSIONS

Eco-Vector